NO20000575D0 - Rekombinant ekspresjon av insulin C-peptid - Google Patents

Rekombinant ekspresjon av insulin C-peptid

Info

Publication number
NO20000575D0
NO20000575D0 NO20000575A NO20000575A NO20000575D0 NO 20000575 D0 NO20000575 D0 NO 20000575D0 NO 20000575 A NO20000575 A NO 20000575A NO 20000575 A NO20000575 A NO 20000575A NO 20000575 D0 NO20000575 D0 NO 20000575D0
Authority
NO
Norway
Prior art keywords
insulin
peptide
recombinant expression
recombinant
expression
Prior art date
Application number
NO20000575A
Other languages
English (en)
Other versions
NO20000575L (no
Inventor
Stefan Stohl
Mathias Uhlen
Per-Ke Nygren
Per Jonasson
Original Assignee
Creative Peptides Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creative Peptides Sweden Ab filed Critical Creative Peptides Sweden Ab
Publication of NO20000575D0 publication Critical patent/NO20000575D0/no
Publication of NO20000575L publication Critical patent/NO20000575L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20000575A 1997-08-07 2000-02-04 Rekombinant ekspresjon av insulin C-peptid NO20000575L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9716790.2A GB9716790D0 (en) 1997-08-07 1997-08-07 Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof
PCT/GB1998/002382 WO1999007735A2 (en) 1997-08-07 1998-08-07 Recombinant expression of insulin c-peptide

Publications (2)

Publication Number Publication Date
NO20000575D0 true NO20000575D0 (no) 2000-02-04
NO20000575L NO20000575L (no) 2000-04-04

Family

ID=10817184

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000575A NO20000575L (no) 1997-08-07 2000-02-04 Rekombinant ekspresjon av insulin C-peptid

Country Status (21)

Country Link
US (1) US6558924B1 (no)
EP (1) EP1001980A1 (no)
JP (1) JP2001512745A (no)
KR (1) KR20010022590A (no)
CN (1) CN1268141A (no)
AU (1) AU750685B2 (no)
BG (1) BG104161A (no)
BR (1) BR9811850A (no)
CA (1) CA2297382A1 (no)
EA (1) EA200000202A1 (no)
EE (1) EE200000072A (no)
GB (1) GB9716790D0 (no)
HU (1) HUP0004626A1 (no)
IL (1) IL134372A0 (no)
IS (1) IS5368A (no)
NO (1) NO20000575L (no)
NZ (1) NZ502450A (no)
PL (1) PL339085A1 (no)
SK (1) SK1532000A3 (no)
TR (1) TR200000288T2 (no)
WO (1) WO1999007735A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040005669A1 (en) * 1997-08-07 2004-01-08 Stefan Stahl Recombinant expression of insulin C-peptide
FR2810675B1 (fr) * 2000-06-22 2002-09-27 Pf Medicament Construction modifiee en aval du codon d'initiation pour la surexpression de proteines recombinantes
FR2810674A1 (fr) * 2000-06-22 2001-12-28 Pf Medicament Construction modifiee en amont du codon d'initiation pour la surexpression de proteines recombinantes
AU3323002A (en) * 2000-12-20 2002-07-01 Hoffmann La Roche Erythropoietin conjugates
CA2475388A1 (en) * 2002-02-14 2003-08-21 William J. Rutter Chimeric molecules for cleavage in a treated host
SG159387A1 (en) 2002-11-26 2010-03-30 Biocon Ltd In Modified natriuretic compounds, conjugates, and uses thereof
US20050026826A1 (en) * 2003-01-17 2005-02-03 Margarethe Hoenig Feline proinsulin, insulin and constituent peptides
AU2003244053A1 (en) * 2003-06-03 2005-01-21 Shanghai Centre Of Research And Development Of New Drugs A fusion protein suitable to be expressed high effectively and the production method thereof
CN1930188B (zh) * 2004-03-10 2012-01-11 克赖顿大学 雌激素受体和使用方法
JP2013533217A (ja) 2010-05-17 2013-08-22 セビックス・インコーポレイテッド Peg化c−ペプチド
US8962553B2 (en) 2011-11-17 2015-02-24 Cebix Ab Method of treating a diabetic subject having a microvascular impairment disorder by a pegylated C-peptide
SG11201405721VA (en) * 2012-03-19 2014-10-30 Madeleine Pharmaceuticals Ρτy Ltd Method of producing a recombinant peptide
CA2979397A1 (en) 2015-03-12 2016-09-15 Board Of Trustees Of Michigan State University Compositions and methods for measuring c-peptide binding and diagnosing immune-mediated diseases
CN109705221B (zh) * 2018-12-27 2021-03-09 美康生物科技股份有限公司 C肽免疫原及其单克隆抗体对及该抗体对在c肽磁微粒化学发光免疫试剂中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5210872B2 (no) 1973-07-14 1977-03-26
GB2068971B (en) 1980-01-30 1983-06-08 Searle & Co Recombinant dna techniques
CA1213537A (en) 1984-05-01 1986-11-04 Canadian Patents And Development Limited - Societe Canadienne Des Brevets Et D'exploitation Limitee Polypeptide expression method
US5013653A (en) 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
WO1988007085A1 (en) 1987-03-20 1988-09-22 Creative Biomolecules, Inc. Process for the purification of recombinant polypeptides
SE501169C2 (sv) 1988-02-05 1994-11-28 Aake Nygren Framställning av serumalbuminbindande fusionsproteiner vilka innehåller protein G-domäner
US5130236A (en) 1989-12-07 1992-07-14 Eli Lilly And Company Process for producing des(64,65)-proinsulin
US5595887A (en) 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
GB9015825D0 (en) 1990-07-18 1990-09-05 Ciba Geigy Ag In vitro processing of fusion proteins
JPH07108232B2 (ja) 1990-10-09 1995-11-22 エム・ディ・リサーチ株式会社 ペプチド又は蛋白質の製造方法
US5953418A (en) 1995-06-14 1999-09-14 David Hall Providing selective data broadcast receiver addressability
CA2213512A1 (en) 1995-12-22 1997-07-03 Toray Industries, Inc. Method for producing bioactive fusion protein

Also Published As

Publication number Publication date
NO20000575L (no) 2000-04-04
WO1999007735A2 (en) 1999-02-18
EP1001980A1 (en) 2000-05-24
CA2297382A1 (en) 1999-02-18
BR9811850A (pt) 2000-08-08
IL134372A0 (en) 2001-04-30
PL339085A1 (en) 2000-12-04
BG104161A (en) 2000-12-29
NZ502450A (en) 2002-10-25
AU750685B2 (en) 2002-07-25
GB9716790D0 (en) 1997-10-15
WO1999007735A3 (en) 1999-04-29
EA200000202A1 (ru) 2001-04-23
TR200000288T2 (tr) 2000-06-21
EE200000072A (et) 2000-10-16
KR20010022590A (ko) 2001-03-26
SK1532000A3 (en) 2000-09-12
IS5368A (is) 2000-02-01
JP2001512745A (ja) 2001-08-28
CN1268141A (zh) 2000-09-27
HUP0004626A1 (hu) 2001-04-28
AU8640798A (en) 1999-03-01
US6558924B1 (en) 2003-05-06

Similar Documents

Publication Publication Date Title
DE69900746D1 (de) Gesteuerte verabreichung von peptiden oder proteinen
NO2010013I1 (no) Rekombinant FSH-CTP
DE4393381T1 (de) Peptide
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
PL336889A1 (en) Preparations of activated protein c
NO983364D0 (no) Konsensusproteiner
NO990059D0 (no) Analoger av kationiske proteiner
FI972657A0 (fi) Proteiinien ja peptidien aerosoliformuloinnit
FI960584L (fi) Terapeuttisia peptidijohdannaisia
FI956310L (fi) Stabiloidut farmaseuttiset peptidikoostumukset
FI954978L (fi) Modifioidut proteiini- ja peptidilääkeaineet
NO976058L (no) Rekombinant mistellectin
FI944802A7 (fi) HLE-proteiinien aktiivisuutta inhiboivat laktaamidipeptidit
EE200000072A (et) Insuliini C-peptiidi rekombinantne ekspressioon
DE69812708D1 (de) Neue arzneimittel enthaltend uridintriphosphat
FI963334L (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
EP1001795A4 (en) RECOMBINANT, VESSEL-FRIENDLY ADENOVIRUS VECTOR CONTAINING A TFPI GENE
ATE283706T1 (de) ßGEGEN RACEMISIERUNG STABILISIERTE PHARMAZEUTISCHE ZUBEREITUNGEN VON CILANSETRONß
DE69232716D1 (de) Peptide mit thrombospondin-ähnlicher Aktivität und ihre therapeutische Verwendung
GB9714680D0 (en) Recombinant production of proteins
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
EP1012262A4 (en) Human frezzled-like protein
IL116973A0 (en) Extraction of recombinant proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application